Sunitinib Malate (CAS 557795-19-4): Your Trusted API Manufacturer and Supplier in China
Discover high-purity Sunitinib Malate, a critical API for advanced cancer treatments. We are a leading manufacturer and supplier in China, offering competitive pricing and reliable supply for your pharmaceutical needs.
Get a Quote & SampleHigh-Quality Sunitinib Malate for Advanced Cancer Therapies
Sunitinib Malate (CAS 557795-19-4)
As a trusted manufacturer and supplier of Sunitinib Malate in China, we provide an API known for its efficacy in treating advanced renal cell carcinoma and gastrointestinal stromal tumors. Our commitment to quality ensures >99% purity, meeting stringent pharmaceutical standards for global clients seeking a reliable source.
- High-Purity Sunitinib Malate API: Sourced and manufactured to pharmaceutical-grade specifications, ensuring efficacy for critical treatments.
- Trusted China Manufacturer & Supplier: Benefit from consistent supply and competitive pricing for your bulk pharmaceutical intermediate needs.
- Key Treatment Applications: Widely used in oncology for advanced renal cell carcinoma and GIST, our API supports vital therapeutic advancements.
- Prompt Global Shipping: We ensure timely delivery within 3-7 working days to meet your production schedules.
Key Advantages of Partnering With Us
Uncompromising Quality Assurance
Our Sunitinib Malate API is manufactured under strict GMP, HSE, ISO 9001, and USP/BP standards, guaranteeing exceptional purity (>99%) for pharmaceutical applications.
Reliable Supply Chain Management
With a production capacity of 1500kg/month, we are a dependable supplier, ensuring continuity for your pharmaceutical manufacturing needs. Buy Sunitinib Malate with confidence from our China facility.
Extensive Industry Experience
Leveraging over 10 years of export experience and multiple patents, we offer unparalleled expertise in API supply, ensuring you receive a premium product and professional service.
Core Applications of Sunitinib Malate
Oncology Treatment
As a vital API, Sunitinib Malate is instrumental in formulations for advanced renal cell carcinoma (RCC) and gastrointestinal stromal tumors (GIST), offering a critical treatment option.
Pharmaceutical Intermediates
We supply Sunitinib Malate as a key intermediate for the synthesis of complex pharmaceutical compounds, supporting research and development in the pharmaceutical sector.
Targeted Cancer Therapies
Its mechanism as a multi-targeted receptor tyrosine kinase inhibitor makes it a cornerstone in the development of advanced, targeted cancer therapies.
Research & Development
Available for purchase, our high-purity Sunitinib Malate supports R&D efforts in discovering new therapeutic applications and improving existing cancer treatments.